TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/26/23 17:49 | 1/25/23 | JSPR | Jasper Therapeutics, Inc. | V8 | Other | Other | American Depositary Receipts | Roche Holding Ltd | V8 | T | S | -142 | 1.89 | 0 | -75 | -2 | 4,550 | I | |||||||||||||||
7/23/20 16:50 | 7/21/20 | PAND | Pandion Therapeutics, Inc. | V8 | Other | Other | American Depositary Receipts | Roche Holding Ltd | V8 | T | P.d | 650 | 18.00 | 0 | 36 | 1 | 3,086 | I | |||||||||||||||
7/5/17 20:27 | 7/5/17 | ALRN | Aileron Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Roche Holding Ltd | V8 | T | P.d | 1,791 | 15.00 | 0 | 119 | 20 | 702 | D | |||||||||||||||
7/6/07 15:27 | 6/26/07 | BIOV | Bioveris Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Roche Holding Ltd | V8 | H | 100% Own | P | 22 | 10.75 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |